Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 26, Issue 12, Pages 1605-1612
Publisher
Springer Nature
Online
2013-06-14
DOI
10.1038/modpathol.2013.113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Personalized therapy in endometrial cancer: Challenges and opportunities
- (2012) Shannon N. Westin et al. CANCER BIOLOGY & THERAPY
- Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma
- (2012) Shinichi Togami et al. CANCER SCIENCE
- Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
- (2012) Hee Eun Lee et al. EUROPEAN JOURNAL OF CANCER
- Does Breast Tumor Heterogeneity Necessitate Further Immunohistochemical Staining on Surgical Specimens?
- (2012) Lauren T. Greer et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Development of targeted therapy in uterine serous carcinoma, a biologically aggressive variant of endometrial cancer
- (2011) Karim S El-Sahwi et al. Expert Review of Anticancer Therapy
- Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections*
- (2011) Stephen Lee et al. HISTOPATHOLOGY
- HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma
- (2011) Yingchuan Hu et al. MODERN PATHOLOGY
- HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population
- (2011) Pamela L. Kunz et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- HER2 Testing in Gastric Cancer
- (2010) Luca Albarello et al. ADVANCES IN ANATOMIC PATHOLOGY
- The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas
- (2010) Aylin Gul et al. Diagnostic Pathology
- Letter to the Editor referring to the manuscript entitled: “Phase II trial of trastuzumab in women with advanced or recurrent HER-positive endometrial carcinoma: a Gynecologic Oncology Group study” recently reported by Fleming et al., (Gynecol Oncol., 116;15–20;2010)
- (2010) Alessandro D. Santin GYNECOLOGIC ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
- (2009) Gini F. Fleming et al. GYNECOLOGIC ONCOLOGY
- HER-2/neu receptor gene status in endometrial carcinomas: a tissue microarray study
- (2009) Mina Xu et al. HISTOPATHOLOGY
- Serous carcinoma of the uterus-determination of HER-2/neu status using immunohistochemistry, chromogenicin situhybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation
- (2008) P. SINGH et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu
- (2008) Alessandro D. Santin et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: A gynecologic oncology group study
- (2007) T.A. Grushko et al. GYNECOLOGIC ONCOLOGY
- HER-2/neuoverexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescencein situhybridization
- (2007) F.E ODICINO et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started